Document Detail


The clinical management of heparin-induced thrombocytopenia.
MedLine Citation:
PMID:  9930559     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Heparin-induced thrombocytopenia (HIT) is an immunologic complication of drug therapy with potentially serious venous and arterial thrombotic sequelae. Recent studies have provided insight into the molecular and cellular basis of HIT underlying the diagnosis and treatment of this syndrome. Because various approaches to HIT treatment have resulted in mixed success, the use of heparin substitutes, other anticoagulant agents, and adjunctive therapy needs to be clarified. For patients with pre-existing conditions such as deep venous thrombosis or pulmonary embolism, new understanding of the clinicopathologic syndrome of HIT offers the promise of improved antithrombotic therapy. The participation of thrombin in HIT suggests that specific (hirudin and argatroban) thrombin inhibitors may be ideal agents for treating acute HIT.
Authors:
J G Kelton
Related Documents :
7978509 - Venous velocity increase with a pneumatic foot compression garment.
3980569 - Screening for the potential pulmonary embolism victim.
18922829 - Lenalidomide in combination with dexamethasone for the treatment of multiple myeloma af...
21502869 - Massive thrombosis of venous aortic coronary bypass graft treated with bivalirudin and ...
11707659 - The acute management of venous thromboembolism in pregnancy.
1423989 - Factors associated with choreoathetosis after cardiopulmonary bypass in children with c...
14751409 - Morphine potentiates dextromethorphan-induced vasodilation in rat superior mesenteric a...
12244429 - Operative and endovascular management of extracranial vertebral artery aneurysm in ehle...
6608869 - Stress scintigraphy using single-photon emission computed tomography in the evaluation ...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Review    
Journal Detail:
Title:  Seminars in hematology     Volume:  36     ISSN:  0037-1963     ISO Abbreviation:  Semin. Hematol.     Publication Date:  1999 Jan 
Date Detail:
Created Date:  1999-06-14     Completed Date:  1999-06-14     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0404514     Medline TA:  Semin Hematol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  17-21     Citation Subset:  IM    
Affiliation:
McMaster University Medical Center, Ontario, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Heparin / adverse effects*
Humans
Thrombocytopenia / chemically induced*,  diagnosis,  drug therapy*
Chemical
Reg. No./Substance:
9005-49-6/Heparin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A mouse model for heparin-induced thrombocytopenia.
Next Document:  Laboratory tests for heparin-induced thrombocytopenia: a multicenter study.